SCHEMBL266281

SCHEMBL266281

NCCc1ccccc1Cl

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 10/20 1.00
PNMT P11086 1/20 0.65
MAOB P27338 3/20 0.59
DPP4 P27487 1/20 0.56
SLC6A2 P23975 1/20 0.55
SLC6A4 P31645 1/20 0.55
SLC6A3 Q01959 1/20 0.55
AOC3 Q16853 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
HTR3E A5X5Y0 1/20 0.53
HTR3B O95264 1/20 0.53
HTR3A P46098 1/20 0.53
HTR3D Q70Z44 1/20 0.53
HTR3C Q8WXA8 1/20 0.53
IDO1 P14902 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29351771 1.00 TAAR1 (1.00) TAAR1PNMTMAOBDPP4SLC6A2
Iodide SCHEMBL30914653 0.98 TAAR1 (0.95) TAAR1PNMTMAOBDPP4SLC6A2
SCHEMBL21848195 0.98 TAAR1 (0.95) TAAR1PNMTMAOBDPP4SLC6A2
Hydrochloric Acid SCHEMBL1847347 0.98 TAAR1 (0.95) TAAR1PNMTMAOBDPP4SLC6A2
Hydrochloric Acid SCHEMBL31521506 0.98 TAAR1 (0.95) TAAR1PNMTMAOBDPP4SLC6A2
Ammonia Solution, Strong SCHEMBL7423333 0.98 TAAR1 (0.95) TAAR1PNMTMAOBDPP4SLC6A2
Alcohol SCHEMBL11556398 0.89 TAAR1 (0.80) TAAR1PNMTMAOBDPP4SLC6A2
Formic Acid SCHEMBL5073848 0.88 TAAR1 (0.77) TAAR1PNMTMAOBDPP4SLC6A2
SCHEMBL3339527 0.86 TAAR1 (0.74) TAAR1PNMTMAOBDPP4SLC6A2
SCHEMBL2025892 0.86 TAAR1 (0.75) TAAR1PNMTMAOBDPP4SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118726998-A Preparation method for preparing benzyl carboxylic acid compound from benzylamine and carbon dioxide 哈尔滨工业大学(深圳) 2024-10-01 CN claimed
US-12075637-B2 Perovskite solar cell and fabrication method thereof CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) 2024-08-27 US claimed
US-20240199542-A1 SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES BAYER AKTIENGESELLSCHAFT (DE) 2024-06-20 US claimed
CN-117859209-A Perovskite solar cell and preparation method thereof 宁德时代新能源科技股份有限公司 2024-04-09 CN claimed
EP-4313943-A1 SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES Bayer Aktiengesellschaft (DE) 2024-02-07 EP claimed
CN-117442609-A Application of tetrahydrocarbazole derivative in preventing and treating cow mastitis pathogenic bacteria 兰州大学 2024-01-26 CN claimed
EP-4300602-A1 PEROVSKITE SOLAR CELL AND PREPARATION METHOD THEREFOR Contemporary Amperex Technology Co., Limited (CN) 2024-01-03 EP claimed
CN-117281120-A Application of tetrahydrocarbazole derivative in preventing and controlling agricultural bacterial diseases 兰州大学 2023-12-26 CN claimed
US-20230403869-A1 PEROVSKITE SOLAR CELL AND FABRICATION METHOD THEREOF CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) 2023-12-14 US claimed
EP-3688131-B1 COMPOSITIONS AND METHODS FOR PREVENTING COLLAPSE OF HIGH ASPECT RATIO STRUCTURES DURING DRYING VERSUM MAT US LLC (US) 2023-08-09 EP claimed
US-20030170918-A1 Low temperature melt-processing of organic-inorganic hybrid INTERNATIONAL BUSINESS MACHINES CORPORATION 2003-09-11 US claimed
WO-2003045385-A1 BENZOTHIAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2003-06-05 WO claimed
US-6417195-B1 LIBRARIES AND COMBINATORIAL CHEMISTRY LION BIOSCIENCE AG (DE) 2002-07-09 US claimed
EP-1126833-A2 OXADIAZOLE, THIADIAZOLE AND TRIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF TREGA BIOSCIENCES, INC. (US) 2001-08-29 EP claimed
WO-2000025768-A1 OXADIAZOLE, THIADIAZOLE AND TRIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF TREGA BIOSCIENCES, INC. (US) 2000-05-11 WO claimed
EP-0863877-A4 ISOQUINOLINE DERIVATIVES AND ISOQUINOLINE COMBINATORIAL LIBRARIES TORREY PINES INST (US) 1999-07-21 EP claimed
US-5874443-A BIOSYNTHESIS TREGA BIOSCIENCES, INC. (US) 1999-02-23 US claimed
EP-0863877-A1 ISOQUINOLINE DERIVATIVES AND ISOQUINOLINE COMBINATORIAL LIBRARIES TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) 1998-09-16 EP claimed
WO-1997016428-A1 ISOQUINOLINE DERIVATIVES AND ISOQUINOLINE COMBINATORIAL LIBRARIES TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) 1997-05-09 WO claimed
US-4209638-A RESOLUTION OF ENANTIOMORPHS THE BOOTS COMPANY LIMITED (GB) 1980-06-24 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240199542-A1 SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES HPD, DDT, PPOX TAAR1 3744/4885PNMT 755/4885MAOB 702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.